Day 1 Recap: Maui Derm NP+PA Fall 2024

Image Credit: © Dermatology Times

To stay informed with the latest conference insights, subscribe to receive our E-newsletters.

Pediatric Pearls From the Literature: Highlights From 2023 and 2024

At Maui Derm NP+PA Fall, Sheila Fallon Friedlander, MD, reviews key findings for the pediatric population from recent dermatology literature, covering topics like cutaneous Crohn’s disease, interrupting the atopic march, advancements in gene therapy, and more.

New Treatments and Breakthroughs in Dermatology: Key Highlights From Maui Derm NP+PA Fall

George Martin, MD, and Ted Rosen, MD, reprise their popular session on new therapies and products with a fast and furious rundown of the current armamentarium across disease states.

Lebrikizumab Shows Promise for Patients with Skin of Color and AD

The IL-13 inhibitor, recently FDA-approved for moderate to severe AD, reached all primary endpoints in the study focusing on patients with skin of color.

Melodie Young, MSN, ANP-c: Key Psoriasis Treatment Advances for Pediatric Patients

At Maui Derm NP+PA Fall 2024, Melodie Young, MSN, ANP-c, reviews new treatment options for pediatric patients with psoriasis and details the difference in disease manifestation between adults and children.

New and Upcoming Psoriasis Therapies with Jason Hawkes, MD

Hawkes highlights groundbreaking therapies for psoriasis, including new oral medications and IL-23 inhibitors.

To view all conference coverage from Maui Derm NP+PA Fall, click here.